Fox Run Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-16,840
| Closed | -$608K | – | 1058 |
|
|
2023
Q2 | $608K | Buy |
16,840
+5,541
| +49% | +$200K | 0.17% | 229 |
|
|
2023
Q1 | $420K | Buy |
+11,299
| New | +$420K | 0.14% | 278 |
|
|
2022
Q4 | – | Sell |
-6,569
| Closed | -$459K | – | 950 |
|
|
2022
Q3 | $459K | Buy |
6,569
+2,937
| +81% | +$205K | 0.18% | 201 |
|
|
2022
Q2 | $244K | Buy |
3,632
+182
| +5% | +$12.2K | 0.12% | 369 |
|
|
2022
Q1 | $284K | Buy |
+3,450
| New | +$284K | 0.16% | 295 |
|
|
2018
Q2 | – | Sell |
-9,744
| Closed | -$299K | – | 962 |
|
|
2018
Q1 | $299K | Buy |
+9,744
| New | +$299K | 0.07% | 493 |
|